
    
      In women who present with biopsy-proven CIN 1, to compare the management approach of regular
      colposcopic follow-up and only treating progressive disease using the LEEP, with an approach
      of immediate treatment using LEEP. The primary outcome is progression to more advanced
      disease (i.e., CIN 2, CIN 3 or cancer).
    
  